AMICUS THERAPEUTICS, INC Overview
Company Headquarters: Cranbury, US
Workforce: ~1,000
Founded: 2002
Company Working:Amicus Therapeutics, Inc (Amicus) is an international, patient-dedicated biotechnology company that develops and delivers innovative, high-quality medications for patients living with rare metabolic diseases. Amicus expanded its business in 27 countries across the globe with headquarters in Cranbury, US. The company’s international offices are located in Canada, Germany, France, Australia, Japan, Italy, the Netherlands, and Spain.
Strategy
Amicus Therapeutics, Inc strategizes to innovate, manufacture, test, and deliver the best quality medicines for people living with rare metabolic diseases. It is also, dedicated to growing a strong pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic disorders such as Pompe and Fabry disease. Amicus focuses on enhancing the clinical data for AT-GAA in ongoing clinical studies to deliver new therapy for people living with Pompe disease.
